Literature DB >> 10537326

Oral cancer chemotherapy: the promise and the pitfalls.

H L McLeod, W E Evans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10537326

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  13 in total

1.  Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment in Turkey.

Authors:  Sultan Kav; Humeyra Bostanci
Journal:  Support Care Cancer       Date:  2006-06-07       Impact factor: 3.603

2.  Prescribing oral chemotherapy.

Authors:  Sandeep D Parsad; Mark J Ratain
Journal:  BMJ       Date:  2007-02-24

3.  Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity.

Authors:  G Klement; S Baruchel; J Rak; S Man; K Clark; D J Hicklin; P Bohlen; R S Kerbel
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

4.  Acid-suppressive agents and survival outcomes in patients with cancer: a systematic review and meta-analysis.

Authors:  Hyun Jin Song; Kiyon Rhew; Yoon Jae Lee; In-Hyuk Ha
Journal:  Int J Clin Oncol       Date:  2020-10-22       Impact factor: 3.402

Review 5.  Oral anticancer drugs in the elderly: an overview.

Authors:  Sara Lonardi; Alberto Bortolami; Micaela Stefani; Silvio Monfardini
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

6.  Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial.

Authors:  Michael P Chu; J Randolph Hecht; Dennis Slamon; Zev A Wainberg; Yung-Jue Bang; Paulo M Hoff; Alberto Sobrero; Shukui Qin; Karen Afenjar; Vincent Houe; Karen King; Sheryl Koski; Karen Mulder; Julie Price Hiller; Andrew Scarfe; Jennifer Spratlin; Yingjie J Huang; Saba Khan-Wasti; Neil Chua; Michael B Sawyer
Journal:  JAMA Oncol       Date:  2017-06-01       Impact factor: 31.777

7.  Clinical trial simulation to evaluate population pharmacokinetics and food effect: capturing abiraterone and nilotinib exposures.

Authors:  Claire H Li; Eric A Sherer; Lionel D Lewis; Robert R Bies
Journal:  J Clin Pharmacol       Date:  2015-02-04       Impact factor: 3.126

8.  Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp.

Authors:  Khalid O Alfarouk; Christian-Martin Stock; Sophie Taylor; Megan Walsh; Abdel Khalig Muddathir; Daniel Verduzco; Adil H H Bashir; Osama Y Mohammed; Gamal O Elhassan; Salvador Harguindey; Stephan J Reshkin; Muntaser E Ibrahim; Cyril Rauch
Journal:  Cancer Cell Int       Date:  2015-07-15       Impact factor: 5.722

9.  Proton pump inhibitors increase the chemosensitivity of patients with advanced colorectal cancer.

Authors:  Xiaoyu Wang; Chun Liu; Jiaqi Wang; Yue Fan; Zhenghua Wang; Yuanyuan Wang
Journal:  Oncotarget       Date:  2017-06-16

10.  Compliance with adjuvant capecitabine in patients with stage II and III colon cancer: comparison of administrative versus medical record data.

Authors:  Adam Amlani; Aalok Kumar; Jenny Y Ruan; Winson Y Cheung
Journal:  Cancer Med       Date:  2016-05-26       Impact factor: 4.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.